In a new job – August 6, 2026
Oxcia appoints new Preclinical Director
“Sandra has been an invaluable member of the Oxcia team, combining scientific excellence with a deep understanding of inflammation as well as our development programs,” says Ulrika Bergman Warpman, CEO. “We are delighted to see her take on this leadership role as we finalize the pre-clinical program for OXC-201 and progress our earlier projects including […]